Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Mycopathologia ; 177(1-2): 115-21, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24381050

RESUMO

Outbreak of exogenous Fusarium endophthalmitis after cataract surgery was evaluated. Twenty patients developed postoperative endophthalmitis. In 19 eyes, pars plana vitrectomy (PPV) was performed, in 14 cases (74 %) with primary intraocular lens explantation. In one case, the PPV was not performed because of poor general condition of the patient. Symptoms of endophthalmitis (damaged vision, iritis, tyndallization in anterior chamber, hypopyon) occurred at intervals of 16-79 days (mean 31.3 days). Fungal etiology was documented in 12 eyes (60 %). Fusarium oxysporum was evidenced by culture and/or microscopy and confirmed by PCR and sequencing analysis. Eighteen (90 %) patients were treated with oral voriconazole (400 mg/day) for a period of 4-6 weeks. The final visual acuity was 6/15 in 1 case (5 %), 6/60 and worse in 17 eyes (85 %), and in 2 cases (10 %), enucleation had to be performed. Viscoelastic filling material was suggested the most likely source of infection. Endophthalmitis caused by Fusarium spp. are a potentially big threat for patients with serious impact on vision. Successful management of the infection is highly dependent on early diagnosis including species identification and antifungal susceptibility testing, and on aggressive and long-term treatment.


Assuntos
Extração de Catarata/efeitos adversos , Endoftalmite/epidemiologia , Fusariose/epidemiologia , Complicações Pós-Operatórias/microbiologia , Idoso , Idoso de 80 Anos ou mais , Antifúngicos/uso terapêutico , Surtos de Doenças , Endoftalmite/tratamento farmacológico , Endoftalmite/microbiologia , Infecções Oculares Fúngicas/tratamento farmacológico , Feminino , Fusariose/tratamento farmacológico , Fusariose/microbiologia , Fusarium/patogenicidade , Humanos , Masculino , Pessoa de Meia-Idade , Pirimidinas/uso terapêutico , Triazóis/uso terapêutico , Vitrectomia , Voriconazol
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA